ANI Pharmaceuticals, Inc. delivered robust 2025 results and issued bullish 2026 guidance. Learn more about ANIP stock here.
For full year 2025, total net revenues, adjusted non-GAAP EBITDA, and adjusted non-GAAP diluted EPS expected to be within or above guidance ...
As such, the results demonstrate that our oral gel platform enhances the delivery of lipophilic cannabinoid molecules and delivers more efficient uptake in the body. These results create a clear ...
The latest update is out from ANI Pharmaceuticals ( (ANIP) ).
There could be new hope in the fight against gum disease. Scientists have developed a toothpaste that targets only the ...
For full year 2025, total net revenues, adjusted non-GAAP EBITDA, and adjusted non-GAAP diluted EPS expected to be within or above guidance ranges of $854 million to $873 million, $221 million to $228 ...
6don MSN
The best pens for journaling, note-taking, drawing and more, approved by authors and editors
Get expert recommendations on the best pens to use from writers and authors. Shop pens from BIC, PaperMate, Sharpie and more ...
TO most, rubella sounds like a virus from a bygone era – something you associate with grainy black-and-white photos of ...
The Avid Outdoorsman on MSN
The real debate over .380 for self-defense (and why it never dies)
The argument over .380 for self-defense never really cools off, because it is not just about ballistics on paper.... The post ...
People who took both Zepbound and an anti-inflammatory drug saw a greater improvement of their psoriatic arthritis symptoms.
Eli Lilly said on Thursday a late-stage trial showed its weight-loss drug Zepbound, used with its psoriatic arthritis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback